Insight Molecular Diagnostics Inc. revenue growth has been varied year-over-year.

What is IMDX's revenue growth rate?

Historical revenue data is available for Insight Molecular Diagnostics Inc. to analyze growth trends.

How fast is IMDX earnings growing?

Earnings growth data is available for Insight Molecular Diagnostics Inc. analysis.

What is IMDX's profit margin?

Profit margin data is available for Insight Molecular Diagnostics Inc..

IMDX Revenue & Earnings Growth Analysis 2026 - Is Insight Molecular Diagnostics Inc. Growing?

Growth Summary

Insight Molecular Diagnostics Inc. (IMDX) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

Over the past 4 years, Insight Molecular Diagnostics Inc. has achieved a revenue compound annual growth rate (CAGR) of 17.6%, while earnings have grown at 44.8% CAGR.

Latest Revenue

$1.88M

Net Income

$-60663000.00

5-Year Revenue CAGR

17.6%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Insight Molecular Diagnostics Inc.

The chart above illustrates Insight Molecular Diagnostics Inc.'s revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Insight Molecular Diagnostics Inc.'s business.

Profit Margin Trends

How efficiently Insight Molecular Diagnostics Inc. converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Insight Molecular Diagnostics Inc. retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$-0.74

Current: $-4.66

EPS Estimate 2027

$-0.87

16.4% expected growth

Price Target

$8.33

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Insight Molecular Diagnostics Inc. to continue focusing on sustainable operations.

Growth Analysis Conclusion

Based on our comprehensive analysis, Insight Molecular Diagnostics Inc. (IMDX) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 17.6% CAGR over 4 years
Profitability: shows the company is investing in growth over short-term profits
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Insight Molecular Diagnostics Inc.'s historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.